Healthier Capital

What Healthier Capital does

Healthier Capital is a healthcare-focused venture capital firm founded in late 2023 and headquartered in Menlo Park, California. The firm invests in technology-powered healthcare innovators with a thesis concentrated on AI-driven diagnostics, care delivery, and clinical workflow platforms. Its investment approach combines capital deployment with operator-led strategic support, drawing on the founding team's prior leadership roles at One Medical, Amazon, Optum/UnitedHealth Group, CVS Health, Stanford, UCLA, and UPMC. The firm is led by Amir Dan Rubin (former One Medical CEO who took the company public in 2020 and sold it to Amazon for $3.9B in 2023) and is supported by a six-person team including Partners Gregor Kevrekian, Eric Epstein, and Aman Mahajan, plus a dedicated Head of Network and Office Manager.

The firm's portfolio comprises approximately 14 healthcare technology companies, including conversational AI agents (Hyro), generative AI infrastructure for health systems (Qualified Health), prescription infrastructure (Photon), ambient clinical intelligence (Suki), AI-driven genomics (Diploid Genomics), multimodal clinical data analytics (Dandelion Health), AI-powered clinical research (Medeloop), radiology AI orchestration (Test Dynamics), cancer care coordination (Daymark Health), pediatric care delivery (Zarminali Pediatrics), and mental health platforms (Octave, Amae Health). Portfolio companies collectively serve more than 30 million patients and span over 500,000 healthcare professionals across systems including Mercy, Emory Healthcare, MD Anderson, NewYork-Presbyterian, Cedars-Sinai, and Stanford Health Care. Healthier Capital led rounds in Daymark, Hyro, Photon, Zarminali, Dandelion, and Diploid Genomics, and co-founded Diploid Genomics with J. Craig Venter.

Revenue is generated through traditional venture fund economics: management fees on committed capital and carried interest on successful exits. The firm's $220 million oversubscribed inaugural fund, closed in January 2026 against a $150 million target, was funded by universities, endowments, family offices, and healthcare organizations. The firm has made nine investments to date and recorded one exit (Ezra acquired by Function Health in May 2025). The go-to-market model centers on operator-led deal sourcing, ecosystem-mediated introductions to health systems and plans, and active portfolio support through a dedicated network function.

Name

Healthier Capital

Legal name

Healthier Capital

Website

https://www.healthiercapital.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Healthier Capital is a healthcare-focused venture capital firm founded in 2023 and based in Menlo Park, investing in AI-driven diagnostics, care delivery, and clinical workflow companies from its $220 million inaugural fund. It serves early-stage health-tech innovators with capital and operator-led strategic support drawn from prior leadership at One Medical, Amazon, Optum, and CVS Health.

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

akta.pro secondary industry

Healthcare & Life Sciences Growth Equity (FSANACAB)

Keywords

• Healthcare venture capital
• Early-stage healthtech investing
• Fund management services
• AI healthcare startups
• Digital health investments

Headquarters

HQ city

Menlo Park

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Fund Management: Healthier Capital generates revenue through traditional venture capital fund mechanics including management fees on committed capital and carried interest (performance fees) from successful portfolio company exits.

Go-to-market motion1 record

Marketing channels4 records

Core offering

Healthier Capital is a venture capital firm that invests in early-stage healthcare technology companies, particularly those leveraging AI across diagnostics, care delivery, and clinical workflows. The firm manages a $220 million oversubscribed inaugural fund (Fund I) backed by universities, endowments, family offices, and healthcare organizations, and has made nine portfolio investments to date. In addition to providing growth capital, the firm offers portfolio companies strategic guidance and ecosystem access drawn from its partners' operator experience at Amazon/One Medical, Optum/UnitedHealth Group, CVS Health, and leading academic medical centers.

Product overview

Healthier Capital is a venture capital firm that partners with technology-powered healthcare innovators to advance healthier outcomes. The firm operates Fund I ($220M) and maintains a portfolio of 14 healthcare technology companies. The portfolio includes AI-driven platforms across multiple healthcare segments: conversational AI agents (Hyro), generative AI infrastructure for hospitals (Qualified Health), prescription infrastructure (Photon), ambient clinical intelligence (Suki), genomics analytics (Diploid Genomics), multimodal clinical data analytics (Dandelion Health), AI-powered clinical research (Medeloop), radiology AI orchestration (Test Dynamics), cancer care coordination (Daymark Health), pediatric care delivery (Zarminali), mental health therapy access (Octave), and severe mental illness treatment (Amae Health). The portfolio companies collectively engage over 30 million patients and cover approximately 7% of U.S. hospital revenue.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthier Capital Fund I An oversubscribed $220 million venture capital fund that invests in early-stage healthcare technology companies leveraging AI and modernized information technologies. The fund is offered to institutional limited partners (universities, endowments, family offices, and healthcare organizations) seeking exposure to healthcare technology venture investments.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability12 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Santé Ventures: Early-stage healthcare-focused venture capital firm where Healthier Capital Partner Eric Epstein previously led the health-tech practice. Directly comparable in thesis, stage focus, and check size within healthcare technology investing.
• Town Hall Ventures: Healthcare-only VC firm that co-led Qualified Health's seed round alongside Healthier Capital. Targets similar early-stage healthcare innovators with operating-partner support, making it a direct peer in both portfolio companies and investment thesis.
• Define Ventures: Early-stage digital health-focused venture firm with similar stage focus and check size to Healthier Capital. Operates with a healthcare-operator thesis and competes for the same seed/Series A healthcare AI deal flow.
• Oak HC/FT: Healthcare-only growth equity firm investing across healthcare services and fintech. Comparable in its healthcare-exclusive focus and partnership model with operators, though typically writing larger checks at later stages.
• SignalFire: Early-to-growth stage venture firm that co-led Qualified Health's seed round with Healthier Capital. While not exclusively healthcare-focused, its AI/data thesis and stage overlap make it a direct co-investor peer.

Broad incumbents

• General Catalyst: Large multi-stage venture firm with one of the most active healthcare practices in the industry. Competes for the same healthcare AI deals but with substantially more capital, deeper follow-on reserves, and broader sector mandates including healthcare services.
• Andreessen Horowitz (a16z Bio): Tier-one venture firm with a dedicated Bio/Health fund investing across healthcare AI, digital health, and bio. Operates at much larger fund sizes and offers broader platform support, competing for premium healthcare AI rounds.
• Khosla Ventures: Large venture firm with significant healthcare AI and digital health exposure. Competes in healthcare AI seed/Series A rounds and brings a substantially larger fund and follow-on capacity than Healthier Capital.
• New Enterprise Associates (NEA): One of the largest venture firms, led the $125M Series B for Healthier Capital portfolio company Qualified Health. Represents the larger end of the competitive set with healthcare-specific partners and much bigger check sizes.
• Bessemer Venture Partners: Long-standing venture firm with a dedicated healthcare practice spanning biotech, healthtech, and healthcare services. Competes for growth-stage healthcare rounds with substantially more capital and a longer historical track record.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/healthier-capital

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments13 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Healthier Capital